Hogan Lovells advised Soliton on the deal. Allergan Aesthetics, an AbbVie company, will acquire Soliton and RESONIC, its Rapid Acoustic Pulse device, for approximately US$550 million....
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here